# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-20-008593
Filing Date
2020-04-10
Accepted
2020-04-10 16:27:31
Documents
5
Period of Report
2020-05-21
Effectiveness Date
2020-04-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | nc10009819x2_def14a.htm | DEF 14A | 1644380
2 |  | davidbthomson_sig.jpg | GRAPHIC | 15437
3 |  | nc10009819x2_pc01.jpg | GRAPHIC | 1269454
4 |  | nc10009819x2_pc02.jpg | GRAPHIC | 908041
5 |  | nc10009819x2_piecharts01.jpg | GRAPHIC | 77869
| Complete submission text file | 0001140361-20-008593.txt |  | 4587118

Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50865 | Film No.: 20786940
SIC: 2834 Pharmaceutical Preparations